Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law How different peptide therapies may affect your body Prenuvo blog The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review